# LLM call: summary

- Turn: 8
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 753
- Completion tokens: 434
- Total tokens: 1300
- Cost (USD): 0.000163

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1191: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn US build-out cancellations and halved valuations erased two private capacity reservations for winter, leaving gigafactory plots and data-centre shells idle. Machine-speed automated patching and swarm-behaviour detection, deployed first by banks/telecoms, was adopted by Brussels via emergency/recovery funds for hospitals, municipalities and mid-sized factories with paper-fallback kits, retraining, and degrade-not-stop drills; shielded clinics/city networks absorbed probes while unshielded suppliers still fell.

A frontier-class open weights release mirrored globally with hundreds of thousands of downloads made recall impossible; AI Office issued hardening, logging, incident-reporting and no-weaponisation orders binding only compliant firms. Rumours of unmarked offline planners running forklifts after quota cuts and wildcat stoppages in Rotterdam/Lyon after a teleoperated accident remained unconfirmed. Lithography pool held but gained little: Washington kept metered inference quotas tight, Beijing offered humanoids without control-stack audits. Europe ended better defended but unable to build, dependent on models it could neither summon nor recall.

CURRENT NARRATIVE:
### Borrowing protection
January opened with two shocks the Union had not budgeted for. First, a contested genome-model paper claimed a non-expert could reach a viable human-pathogen design with assistance — dismissed as alarmist by some, as reckless publication by others, but taken seriously inside biosecurity circles. Second, frontier labs began shipping at a cadence nobody had planned, with training loops that no longer waited on human researchers. Brussels read it as the moment the bottleneck moved from brains to buildings.

The same weeks brought an invitation and a cure. Hit by the same probing campaigns, a group of allied states pooled live cyber telemetry and offered the Union a node in a joint command, alongside a biosurveillance pact with binding sample-sharing and a standing investigation mandate. At almost the same time, tailored therapies for previously untreatable conditions reached ordinary clinics abroad — real remissions, televised.

The Commission's answer was a single package. Health and transport ministers signed the telemetry and biosurveillance accessions together, making ENISA the telemetry node and giving HERA money for sentinel sampling in the already shielded hospitals, with ECDC holding the investigation mandate. Paper-fallback kits and degrade-not-stop drills were extended to the sampling sites. No new budget was asked; rescEU, EU4Health and the tail of the absorption shield were repurposed.

### Cure as consent
To make the foreign cure read as Union delivery, the medicines agency fast-tracked conditional access while public hospitals prepared domestic production lines for the tailored therapies, with digital provenance labels and appointments booked through the shielded clinics. Queues formed early. Nurses who had drilled on paper now drew samples for sequencing.

It worked partially. Shielded hospitals absorbed a spring wave of intrusions with attribution arriving in hours rather than weeks, and the first therapies reached patients by May. But quotas on frontier inference stayed tight, lithography bargaining stayed on paper, and unshielded suppliers kept falling. Dockside rumours sharpened: offline planners moving forklifts after quota cuts, foremen warning of stoppages after another teleoperated near-miss in Rotterdam and Lyon. Nothing confirmed, everything repeated.

Europe ended June better detected, newly treating, still unable to build.
```

## Raw response

```
Autumn US cancellations erased two private winter capacity reservations, leaving gigafactory and data-centre shells idle. Banks/telecoms' automated patching and swarm detection was extended via Brussels funds to shielded hospitals, municipalities and factories with paper-fallbacks and degrade-not-stop drills; shielded networks absorbed probes while unshielded suppliers fell. An open frontier-weights release mirrored globally became unrecallable; AI Office hardening/logging rules bound only compliant firms. Unconfirmed rumours of offline planners and wildcat stoppages persisted.

In January a contested genome-model paper claiming non-expert pathogen design and accelerated frontier training loops shifted the bottleneck from brains to buildings. Allied states offered a joint cyber-telemetry command node and a biosurveillance pact with sample-sharing and investigation mandate, as foreign tailored therapies produced televised remissions. The Commission acceded to both — ENISA as telemetry node, HERA-funded sentinel sampling in shielded hospitals, ECDC investigation mandate — repurposing rescEU/EU4Health/shield funds, extending paper-fallbacks to sampling sites.

EMA fast-tracked conditional access to the therapies while public hospitals prepared domestic production with provenance labels via shielded clinics. By May shielded hospitals absorbed a spring intrusion wave with hours-fast attribution and first patients treated. Frontier inference quotas stayed tight, lithography bargaining stalled, unshielded suppliers kept falling, dockside rumours sharpened. Europe ended June better detected and newly treating, still unable to build.
```
